Stimulant Abuser Groups to Engage in 12-Step

University of Washington471 enrolled

Overview

The purpose of this study is to determine whether a combined group and individual 12-Step facilitative (TSF) intervention, Stimulant Abuser Groups to Engage in 12 -Step (STAGE-12), improves substance -related outcomes.

This protocol is to evaluate the degree to which a combined group and individual 12-Step facilitative (TSF) intervention, Stimulant Abuser Groups to Engage in 12 -Step (STAGE-12), improves substance -related outcomes compared to treatment as usual (TAU) without STAGE-12 among stimulant abusers. The primary objective is to evaluate reduction in percent of days of stimulant use as measured by self-report. Secondary objectives include evaluating reduction in percent days of use of other substances, the degree to which STAGE-12 increases involvement in 12-step activities and attendance at 12-step meetings, and the extent to which such 12 -step involvement and meeting attendance mediate substance use outcomes.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

471

Conditions

Drug Abuse

Interventions

STAGE-12BEHAVIORAL

The STAGE-12 intervention will consist of a combination of five group and three individual sessions. The five group sessions will be taken from the Project MATCH Twelve Step Facilitation manual as modified for use with drug abusers and adapted for delivery in a group format. The group sessions will be augmented by three individual sessions derived from the introductory and termination sessions from the TSF manual and incorporating elements of the brief intensive 12-step referral procedure.

Treatment as UsualBEHAVIORAL

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * seeking outpatient treatment for stimulant abuse or dependence * current diagnosis of stimulant abuse or dependence * willing to participate in the protocol Exclusion Criteria: * not sufficiently medically or psychiatrically stable * pending legal action that would inhibit their participation in the study * in need of detoxification from opiates

Locations (10)

Gateway Community Services

Jacksonville, Florida, United States

Hina Mauka Kaneohe Rehabilitation Services

Kaneohe, Hawaii, United States

Maryhaven, Inc.

Columbus, Ohio, United States

Outcomes

Primary Outcomes

Days of Stimulant Use

Number of days of use of stimulant drugs within 30-day blocks across a 6-month post-baseline period

Time frame: 6 months

Secondary Outcomes

Attendance at 12-step Meetings

Days of attendance at 12-step meetings within 30-day blocks across a 6-month post-baseline period

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.